PHATPHATHOM PHARMACEUTICALS INC
CUSIP 71722W107 · common stock
1 tracked investor held PHATHOM PHARMACEUTICALS INC (PHAT) at the end of Q3 2026, worth $313.2K. The largest holder was Adar1 Capital Management, with 0.0% of its portfolio. Perceptive Advisors sold out of its position this quarter.
Holders · Q3 2026
1
New holders
0
Value held
$313.2K
Quarter-end price (est.)
$7.30
Investors holding PHAT · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.01% | 42,900 | $313.2K | HOLD |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Perceptive Advisors | 0.09% | 532,000 | $5.8M | EXIT |